Wittycell SAS
http://www.wittycell.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Wittycell SAS
Asia To Get ‘Cost Competitive’ Vaccines From Abivax Deal
Several countries in Asia are set to see the availability of additional vaccines for the prevention of some of the most common bacterial diseases in the region, by way of an alliance between a new European venture and a Cuban scientific research institute.
Newly Formed Abivax Of France Links With Cuba To Develop Vaccines
New French biotech Abivax is tapping into Cuba’s vaccine expertise in hopes of becoming a leader in the field, initially targeting Asia with its lead hepatitis B jab, which it says offers the potential to cure the disease.
Newly Formed Abivax Of France Links With Cuba To Develop Vaccines
New French biotech Abivax is tapping into Cuba’s vaccine expertise in hopes of becoming a leader in the field, initially targeting Asia with its lead Hepatitis B jab, which it says offers the potential to cure the disease.
Recent Tech Transfer Deals (3/07)
Each month, Start-Up presents a survey of technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice